Cargando…
Willingness to Pay for COVID-19 Vaccines in Japan
More than 80% of the Japanese population had received the coronavirus disease 2019 (COVID-19) vaccination by the end of April 2023; however, this vaccination rate continues to decline along with the need for booster shots. Further, the vaccines may not permanently be available free of charge. This s...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671273/ https://www.ncbi.nlm.nih.gov/pubmed/37998275 http://dx.doi.org/10.3390/ijerph20227044 |
_version_ | 1785140115506462720 |
---|---|
author | Yoda, Takeshi Iwasaki, Nagisa Katsuyama, Hironobu |
author_facet | Yoda, Takeshi Iwasaki, Nagisa Katsuyama, Hironobu |
author_sort | Yoda, Takeshi |
collection | PubMed |
description | More than 80% of the Japanese population had received the coronavirus disease 2019 (COVID-19) vaccination by the end of April 2023; however, this vaccination rate continues to decline along with the need for booster shots. Further, the vaccines may not permanently be available free of charge. This study conducted a survey to determine the public’s willingness to pay for the COVID-19 vaccine in Japan. Using an internet research panel, the questionnaire collected data on various sociodemographic variables and the respondents’ willingness to pay for COVID-19 vaccines. Descriptive statistics and logistic regression analysis were used to evaluate the respondents’ answers. The results showed that of 1100 respondents, 55.2% would not want to receive the vaccine if it was paid for. A total of 44.8% respondents expressed willingness to pay, with most (170 respondents) willing to pay for 1000–1999 JPY (7.1–14.2 USD). Logistic regression analysis revealed that age, educational status, history of contracting COVID-19, and COVID-19 vaccination frequency were significantly associated with those who were willing to receive the COVID-19 vaccine if it was free (p < 0.05). These findings provide valuable insights for the Japanese government in determining appropriate pricing strategies to promote COVID-19 vaccination effectively. |
format | Online Article Text |
id | pubmed-10671273 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106712732023-11-09 Willingness to Pay for COVID-19 Vaccines in Japan Yoda, Takeshi Iwasaki, Nagisa Katsuyama, Hironobu Int J Environ Res Public Health Article More than 80% of the Japanese population had received the coronavirus disease 2019 (COVID-19) vaccination by the end of April 2023; however, this vaccination rate continues to decline along with the need for booster shots. Further, the vaccines may not permanently be available free of charge. This study conducted a survey to determine the public’s willingness to pay for the COVID-19 vaccine in Japan. Using an internet research panel, the questionnaire collected data on various sociodemographic variables and the respondents’ willingness to pay for COVID-19 vaccines. Descriptive statistics and logistic regression analysis were used to evaluate the respondents’ answers. The results showed that of 1100 respondents, 55.2% would not want to receive the vaccine if it was paid for. A total of 44.8% respondents expressed willingness to pay, with most (170 respondents) willing to pay for 1000–1999 JPY (7.1–14.2 USD). Logistic regression analysis revealed that age, educational status, history of contracting COVID-19, and COVID-19 vaccination frequency were significantly associated with those who were willing to receive the COVID-19 vaccine if it was free (p < 0.05). These findings provide valuable insights for the Japanese government in determining appropriate pricing strategies to promote COVID-19 vaccination effectively. MDPI 2023-11-09 /pmc/articles/PMC10671273/ /pubmed/37998275 http://dx.doi.org/10.3390/ijerph20227044 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yoda, Takeshi Iwasaki, Nagisa Katsuyama, Hironobu Willingness to Pay for COVID-19 Vaccines in Japan |
title | Willingness to Pay for COVID-19 Vaccines in Japan |
title_full | Willingness to Pay for COVID-19 Vaccines in Japan |
title_fullStr | Willingness to Pay for COVID-19 Vaccines in Japan |
title_full_unstemmed | Willingness to Pay for COVID-19 Vaccines in Japan |
title_short | Willingness to Pay for COVID-19 Vaccines in Japan |
title_sort | willingness to pay for covid-19 vaccines in japan |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671273/ https://www.ncbi.nlm.nih.gov/pubmed/37998275 http://dx.doi.org/10.3390/ijerph20227044 |
work_keys_str_mv | AT yodatakeshi willingnesstopayforcovid19vaccinesinjapan AT iwasakinagisa willingnesstopayforcovid19vaccinesinjapan AT katsuyamahironobu willingnesstopayforcovid19vaccinesinjapan |